FURIN-HEMMER

Patent europeic · EP3790871 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3790871
Numer da la dumonda: EP19725058
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 10-05-2019
Publitgà: 17-03-2021
Concedì: 24-01-2024
La protecziun finescha il pli tard: 09-05-2039
Proxima taxa annuala scadenta: 31-05-2027
Classas IPC: C07D 401/14 (2006.01)
A61K 31/44 (2006.01)
A61K 31/4427 (2006.01)
C07D 213/76 (2006.01)
C07D 401/04 (2006.01)
C07D 413/12 (2006.01)
Prioritad: US 201862670050 P 11.05.2018
Dumonda PCT: PCT/EP2019/062098 10.05.2019
Publicaziun PCT: WO2019/215341 14.11.2019
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-06-2026
Midada
Published in Swissreg on 01.06.2026
07-11-2025
Adressa dal possessur midada
Owner
GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Published in Swissreg on 07.11.2025
01-06-2025
Midada
Published in Swissreg on 01.06.2025
04-12-2024
Midada
Published in Swissreg on 04.12.2024
02-06-2024
Midada
Published in Swissreg on 02.06.2024
24-01-2024
Concedì
Published in Swissreg on 24.01.2024

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB